The global healthcare specialty enzymes market is anticipated to reach market size of around US$ 8,000 Mn by 2027 and is anticipated to grow at a CAGR of around 9% in terms of revenue during the forecast period 2020 - 2027.
Protein macromolecules are enzymes acting as a biocatalyst that facilitate reaction rates, without altering chemistry. Many chemical reactions, most of them controlled by enzymes, take place in all living organisms. Depletion of the body's enzyme capacity often results in pain, indigestion, swelling, immune deficit and many more. The use of traditional medicinal products only provides temporary relief, while enzymes are used by binding multiple target molecules to the target site to reduce the underlying cause of health problem. Valuable medicinal and industrial application is given to specialty enzymes.
Market Insights
Included in the market for the health care specialist enzymes are such reasons as increased occurrence of metabolic disorders related to the abnormality of the enzymes and incorporations of enzymes as indicators of diseases during clinical exams. In addition, increased demand for pharmaceuticals, substantial financial support for the field of biotechnology and breakthroughs in enzyme engineering & green chemicals will further fuel market patterns over the next decade. The quickly developing regional market and growing clinical in vitro diagnostics would also provide the health-related enzymes sector with new growth opportunities. In addition, the introduction of DNA sequencing techniques and dynamic molecular diagnostics will further intensify the development of business development for healthcare specialty in the coming years. Factories such as growing demand for medicine prevention. Increased occurrence of enzyme abnormality-related metabolic disorders and the integration of enzymes as disease measures in clinical examinations contribute to market growth.
The demand of health specialty enzymes was led by North America and represented the biggest share of revenue in 2019 by 38.2%. The country has the main industry contributor to the high penetration of enzyme technology of more than US$ 900 Mn. Furthermore, the expanding sales and distributors in the area are likely to increase the need of the region's health specialty enzymes. The involvement of key players in the U.S. has provided easy, diagnostic and analysis access to emerging enzymes. Creative enzymes, for example, located in the US; provide enzymes which are useful for medical research, chemical and environmental safety. In addition, the company manufactures cell biology, chemical manufacturing and antibody testing enzymes. In Asia-Pacific, a broad consumption base for diagnostic consumables and reagents is expected to increase the specialty enzyme demand in the region.
Recent Developments
DuPont Nutrition & Biosciences has launched its leading industry portfolio OPTIMASE. This portfolio includes biological enzymes used for medical device washing. The food selection aims to achieve good efficiency and reduce the ingredients that maintain the enzymes and thus save room and costs.
The company's enzyme supply has been signed by Roche Holding (Switzerland) and Codexis (U.S.). EvoT4 DNA Ligase will be supplied to Roche with Codexis. EvoT4 is a molecular diagnostic enzyme with a high degree of efficiency.
BASF (Germany), the leader in biotechnological science, entered into a cooperation agreement with Conagen (US). Conagen has high research and development potential for fermented ingredients. This decision would encourage BASF to supply one of the most requested fragrance ingredients, the natural vanillin, on the market.
In East Africa, its presence in Novozymes (Denmark) has increased. The organization was thus able to satisfy the customers ' expectations for the region's enzyme products.
In Framingham, Massachusetts, Sanofi (France) opened the first digitally activated production plant. The new factory has the technology to connect production process with research and development. The promotion of new drugs is also increased.
The prominent players in the healthcare specialty enzymes market include Codexis, Novozymes, Affymetrix, Amicogen, Amano Enzymes, Advanced Enzymes Technologies, Biocatalysts, Roche Custombiotech, S Bbi Solutions, ekisui Diagnostics, Hoffmann-la Roche, Merck, Amano Enzymes, and others.
The global healthcare specialty enzymes market is segmented as below:
Market Segmentation
Healthcare Specialty Enzymes Market By Type
Oxidase
Nucleases
Restriction Enzymes
Polymerases
Lipases
Amylases
Others
Healthcare Specialty Enzymes Market By Source
Micro-organisms
Plants
Animals
Healthcare Specialty Enzymes Market By Application
Pharmaceuticals
Research & Biotechnology
Diagnostic
Bio-Catalyst
Healthcare Specialty Enzymes Market By Geography
North America
Europe
- UK
- Germany
- France
- Spain
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Mexico
- Rest of Latin America
Middle East & Africa
- GCC
- South Africa
- Rest of Middle East & Africa
CHAPTER 1. Overview of Healthcare Specialty Enzymes
1.1. Definition Industry and Scope
1.1.1. Definition of Healthcare Specialty Enzymes
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global Healthcare Specialty Enzymes Market
1.2. Summary
1.2.1. Executive Summary
1.2.2. Healthcare Specialty Enzymes Market By Type
1.2.3. Healthcare Specialty Enzymes Market By Source
1.2.4. Healthcare Specialty Enzymes Market By Application
1.2.5. Healthcare Specialty Enzymes Market by Regions
CHAPTER 2. Research Approach
2.1. Methodology
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data Source
2.2.1. Secondary Sources
2.2.2. Primary Sources
CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.2. Restraints and Challenges
3.2.1. Restrain 1
3.2.2. Restrain 2
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Market Concentration Ratio And Market Maturity Analysis of Healthcare Specialty Enzymes Market
3.5.1. Go To Market Strategy
3.6. Technological Roadmap for Healthcare Specialty Enzymes Market
3.7. Value Chain Analysis
3.7.1. List of Key Manufacturers
3.7.2. List of Customers
3.7.3. Level of Integration
3.8. Cost Structure Analysis
3.9. Regulatory Compliance
3.10. Competitive Landscape, 2019
3.10.1. Player Positioning Analysis
3.10.2. Key Strategies Adopted By Leading Players
CHAPTER 4. Manufacturing Plant Analysis
4.1. Manufacturing Plant Location and Establish Date Global for Healthcare Specialty Enzymes Major Manufacturers in 2019
4.2. R&D Status and By Source Source of Global Healthcare Specialty Enzymes Major Manufacturers in 2019
CHAPTER 5. Healthcare Specialty Enzymes Market By Type
5.1. Introduction
5.2. Healthcare Specialty Enzymes Revenue By Type
5.2.1. Healthcare Specialty Enzymes Revenue (US$ Mn) and Forecast, By Type, 2016-2027
5.2.2. Oxidase
5.2.2.1. Oxidase Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.3. Nucleases
5.2.3.1. Nucleases Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.4. Restriction Enzymes
5.2.4.1. Restriction Enzymes Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.5. Polymerases
5.2.5.1. Polymerases Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.6. Lipases
5.2.6.1. Lipases Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.7. Amylases
5.2.7.1. Amylases Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.8. Others
5.2.8.1. Others Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
CHAPTER 6. Healthcare Specialty Enzymes Market Revenue By Source
6.1. Introduction
6.2. Healthcare Specialty Enzymes Revenue (US$ Mn) By Source
6.2.1. Healthcare Specialty Enzymes Revenue (US$ Mn) and Forecast By Source, 2016 - 2027
6.2.2. Micro-organisms
6.2.2.1. Micro-organisms Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
6.2.3. Plants
6.2.3.1. Plants Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
6.2.4. Animals
6.2.4.1. Animals Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
CHAPTER 7. Healthcare Specialty Enzymes Market By Application
7.1. Introduction
7.2. Healthcare Specialty Enzymes Revenue (US$ Mn) By Application
7.2.1. Healthcare Specialty Enzymes Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
7.2.2. Pharmaceuticals
7.2.2.1. Pharmaceuticals Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
7.2.3. Research & Biotechnology
7.2.3.1. Research & Biotechnology Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
7.2.4. Diagnostic
7.2.4.1. Diagnostic Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
7.2.5. Bio-Catalyst
7.2.5.1. Bio-Catalyst Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
CHAPTER 8. North America Healthcare Specialty Enzymes Market By Country
8.1. North America Healthcare Specialty Enzymes Overview
8.2. U.S.
8.2.1. U.S. Healthcare Specialty Enzymes Market Revenue (US$ Mn) and Forecast By Type, 2016-2027
8.2.2. U.S. Healthcare Specialty Enzymes Market Revenue (US$ Mn) and Forecast By Source, 2016-2027
8.2.3. U.S. Healthcare Specialty Enzymes Market Revenue (US$ Mn) and Forecast By Application, 2016-2027
8.3. Canada
8.3.1. Canada Healthcare Specialty Enzymes Market Revenue (US$ Mn) and Forecast By Type, 2016-2027
8.3.2. Canada Healthcare Specialty Enzymes Market Revenue (US$ Mn) and Forecast By Source, 2016-2027
8.3.3. Canada Healthcare Specialty Enzymes Market Revenue (US$ Mn) and Forecast By Application, 2016-2027
8.4. North America PEST Analysis
CHAPTER 9. Europe Healthcare Specialty Enzymes Market By Country
9.1. Europe Bioanlytical Testing Services Market Overview
9.2. U.K.
9.2.1. U.K. Healthcare Specialty Enzymes Market Revenue (US$ Mn) and Forecast By Type, 2016-2027
9.2.2. U.K. Healthcare Specialty Enzymes Market Revenue (US$ Mn) and Forecast By Source, 2016-2027
9.2.3. U.K. Healthcare Specialty Enzymes Market Revenue (US$ Mn) and Forecast By Application, 2016-2027
9.3. Germany
9.3.1. Germany Healthcare Specialty Enzymes Market Revenue (US$ Mn) and Forecast By Type, 2016-2027
9.3.2. Germany Healthcare Specialty Enzymes Market Revenue (US$ Mn) and Forecast By Source, 2016-2027
9.3.3. Germany Healthcare Specialty Enzymes Market Revenue (US$ Mn) and Forecast By Application, 2016-2027
9.4. France
9.4.1. France Healthcare Specialty Enzymes Market Revenue (US$ Mn) and Forecast By Type, 2016-2027
9.4.2. France Healthcare Specialty Enzymes Market Revenue (US$ Mn) and Forecast By Source, 2016-2027
9.4.3. France Healthcare Specialty Enzymes Market Revenue (US$ Mn) and Forecast By Application, 2016-2027
9.5. Spain
9.5.1. Spain Healthcare Specialty Enzymes Market Revenue (US$ Mn) and Forecast By Type, 2016-2027
9.5.2. Spain Healthcare Specialty Enzymes Market Revenue (US$ Mn) and Forecast By Source, 2016-2027
9.5.3. Spain Healthcare Specialty Enzymes Market Revenue (US$ Mn) and Forecast By Application, 2016-2027
9.6. Rest of Europe
9.6.1. Rest of Europe Healthcare Specialty Enzymes Market Revenue (US$ Mn) and Forecast By Type, 2016-2027
9.6.2. Rest of Europe Healthcare Specialty Enzymes Market Revenue (US$ Mn) and Forecast By Source, 2016-2027
9.6.3. Rest of Europe Healthcare Specialty Enzymes Market Revenue (US$ Mn) and Forecast By Application, 2016-2027
9.7. Europe PEST Analysis
CHAPTER 10. Asia Pacific Healthcare Specialty Enzymes Market By Country
10.1. Asia Pacific Healthcare Specialty Enzymes Market Overview
10.2. China
10.2.1. China Healthcare Specialty Enzymes Market Revenue (US$ Mn) and Forecast By Type, 2016 - 2027
10.2.2. China Healthcare Specialty Enzymes Market Revenue (US$ Mn) and Forecast By Source, 2016 - 2027
10.2.3. China Healthcare Specialty Enzymes Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
10.3. Japan
10.3.1. Japan Healthcare Specialty Enzymes Market Revenue (US$ Mn) and Forecast By Type, 2016 - 2027
10.3.2. Japan Healthcare Specialty Enzymes Market Revenue (US$ Mn) and Forecast By Source, 2016 - 2027
10.3.3. Japan Healthcare Specialty Enzymes Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
10.4. India
10.4.1. India Healthcare Specialty Enzymes Market Revenue (US$ Mn) and Forecast By Type, 2016 - 2027
10.4.2. India Healthcare Specialty Enzymes Market Revenue (US$ Mn) and Forecast By Source, 2016 - 2027
10.4.3. India Healthcare Specialty Enzymes Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
10.5. Australia
10.5.1. Australia Healthcare Specialty Enzymes Market Revenue (US$ Mn) and Forecast By Type, 2016 - 2027
10.5.2. Australia Healthcare Specialty Enzymes Market Revenue (US$ Mn) and Forecast By Source, 2016 - 2027
10.5.3. Australia Healthcare Specialty Enzymes Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
10.6. South Korea
10.6.1. South Korea Healthcare Specialty Enzymes Market Revenue (US$ Mn) and Forecast By Type, 2016 - 2027
10.6.2. South Korea Healthcare Specialty Enzymes Market Revenue (US$ Mn) and Forecast By Source, 2016 - 2027
10.6.3. South Korea Healthcare Specialty Enzymes Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
10.7. Rest of Asia-Pacific
10.7.1. Rest of Asia-Pacific Healthcare Specialty Enzymes Market Revenue (US$ Mn) and Forecast By Type, 2016 - 2027
10.7.2. Rest of Asia-Pacific Healthcare Specialty Enzymes Market Revenue (US$ Mn) and Forecast By Source, 2016 - 2027
10.7.3. Rest of Asia-Pacific Healthcare Specialty Enzymes Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
10.8. Asia Pacific PEST Analysis
CHAPTER 11. Latin America Healthcare Specialty Enzymes Market By Country
11.1. Latin America Healthcare Specialty Enzymes Market Overview
11.2. Brazil
11.2.1. Brazil Healthcare Specialty Enzymes Market Revenue (US$ Mn) and Forecast By Type, 2016 - 2027
11.2.2. Brazil Healthcare Specialty Enzymes Market Revenue (US$ Mn) and Forecast By Source, 2016 - 2027
11.2.3. Brazil Healthcare Specialty Enzymes Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
11.3. Mexico
11.3.1. Mexico Healthcare Specialty Enzymes Market Revenue (US$ Mn) and Forecast By Type, 2016 - 2027
11.3.2. Mexico Healthcare Specialty Enzymes Market Revenue (US$ Mn) and Forecast By Source, 2016 - 2027
11.3.3. Mexico Healthcare Specialty Enzymes Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
11.4. Rest of Latin America
11.4.1. Rest of Latin America Healthcare Specialty Enzymes Market Revenue (US$ Mn) and Forecast By Type, 2016 - 2027
11.4.2. Rest of Latin America Healthcare Specialty Enzymes Market Revenue (US$ Mn) and Forecast By Source, 2016 – 2027
11.4.3. Rest of Latin America Healthcare Specialty Enzymes Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
CHAPTER 12. Middle East & Africa Healthcare Specialty Enzymes Market By Country
12.1. Middle East & Africa Healthcare Specialty Enzymes Market Overview
12.2. Saudi Arabia
12.2.1. Saudi Arabia Healthcare Specialty Enzymes Market Revenue (US$ Mn) and Forecast By Type, 2016 - 2027
12.2.2. Saudi Arabia Healthcare Specialty Enzymes Market Revenue (US$ Mn) and Forecast By Source, 2016 - 2027
12.2.3. Saudi Arabia Healthcare Specialty Enzymes Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
12.3. UAE
12.3.1. UAE Healthcare Specialty Enzymes Market Revenue (US$ Mn) and Forecast By Type, 2016 - 2027
12.3.2. UAE Healthcare Specialty Enzymes Market Revenue (US$ Mn) and Forecast By Source, 2016 - 2027
12.3.3. UAE Healthcare Specialty Enzymes Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
12.4. Rest of Middle East & Africa
12.4.1. Rest of Middle East & Africa Healthcare Specialty Enzymes Market Revenue (US$ Mn) and Forecast By Type, 2016 - 2027
12.4.2. Rest of Middle East & Africa Healthcare Specialty Enzymes Market Revenue (US$ Mn) and Forecast By Source, 2016 - 2027
12.4.3. Rest of Middle East & Africa Healthcare Specialty Enzymes Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
CHAPTER 13. PLAYER ANALYSIS OF STROKE MANAGEMENT
13.1. Healthcare Specialty Enzymes Market Company Share Analysis
13.2. Competition Matrix
13.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment
13.2.2. New Source Launches and Source Enhancements
13.2.3. Mergers And Acquisition In Global Healthcare Specialty Enzymes Market
13.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements
CHAPTER 14. COMPANY PROFILE
14.1. Codexis
14.1.1. Company Snapshot
14.1.2. Business Overview
14.1.3. Financial Overview
14.1.3.1. Revenue (US$ Mn), 2019
14.1.3.2. Codexis 2019 Healthcare Specialty Enzymes Business Regional Distribution
14.1.4. Source/ Service and Specification
14.1.5. Recent Developments & Business Strategy
14.1.6. Manufacturing Plant Footprint Analysis
14.2. Novozymes
14.3. Affymetrix
14.4. Amicogen
14.5. Amano Enzymes
14.6. Advanced Enzymes Technologies
14.7. Biocatalysts
14.8. Roche Custombiotech
14.9. S Bbi Solution
14.10. ekisui Diagnostics
14.11. Hoffmann-la Roche
14.12. Merck
14.13. Amano Enzymes
14.14. Others
